Biomarkers in Gynecology and Obstetrics

In: The Handbook of Biomarkers · 2017 · pp. 689–700 · doi:10.1007/978-1-4939-7431-3_17 · W2754964890
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-13

This chapter discusses biomarkers for menopause, endometriosis, and pregnancy disorders, noting that fewer women's health biomarkers have been investigated compared to other areas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

This chapter surveys biomarkers relevant to women’s health, with particular emphasis on biomarkers of menopause and on disorders associated with pregnancy, while noting that breast and ovarian cancer biomarkers are discussed elsewhere. It includes endometriosis among the covered gynecologic topics and provides a referenced overview spanning diverse biomarker types and discovery/validation approaches cited in the text. A key limitation explicitly implied by the chapter format is that it is not an original study with a single analytic population or new dataset, but rather a compilation of prior work. Relevance to endometriosis: the paper explicitly includes endometriosis in the chapter’s stated scope of “biomarkers of menopause, endometriosis and disorders associated with pregnancy,” though its main content is a general biomarker overview rather than original endometriosis research.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 5,134 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Biomarkers relevant to women’s health have not been investigated as widely as in some other therapeutic areas. Those relevant to cancer of breast and ovaries are discussed in the chapter on cancer biomarkers. This section will deal with biomarkers of menopause, endometriosis and disorders associated with pregnancy. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Adachi J, Kumar C, Zhang Y, et al. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 2006;7:R80. Ajayi F, Kongoasa N, Gaffey T, et al. Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion. Am J Obstet Gynecol. 2008;199:557.e1–557.e10. Austdal M, Tangerås LH, Skråstad RB, et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int J Mol Sci. 2015;16:21520–38. Bradford C, Severinsen R, Pugmire T, et al. Analytical validation of protein biomarkers for risk of spontaneous preterm birth. Clin Mass Spectrom. 2017;3:25–38. Bramham K, Seed PT, Lightstone L, et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 2016;89:874–85. Cantonwine DE, Zhang Z, Rosenblatt K, et al. Evaluation of proteomic biomarkers associated with circulating microparticles as an effective means to stratify the risk of spontaneous preterm birth. Am J Obstet Gynecol. 2016;214:631.e1–631.e11. Diaz SO, Pinto J, Graça G, et al. Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res. 2011;10:3732–42. Flores I, Rivera E, Mousses S, et al. Identification of molecular markers for endometriosis in blood lymphocytes by using deoxyribonucleic acid microarrays. Fertil Steril. 2006;85:1676–83. Gormley M, Ona K, Kapidzic M, et al. Preeclampsia: novel insights from global RNA profiling of trophoblast subpopulations. Am J Obstet Gynecol. 2017;pii:S0002-9378(17)30441–6. Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas. 2009;63:280–91. Maron JL, Johnson KL, Slonim D, et al. Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. Clin Invest. 2007;117:3007–19. Norwitz ER, Tsen LC, Park JS, et al. Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol. 2005;193:957–64. Othman E-D, Hornung D, Salem HT, et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;137:240–6. Ramiro-Cortijo D, Herrera T, Rodríguez-Rodríguez P, et al. Maternal plasma antioxidant status in the first trimester of pregnancy and development of obstetric complications. Placenta. 2016;47:37–45. Saarela T, Hiltunen M, Helisalmi S, et al. Adiponectin gene haplotype is associated with preeclampsia. Genet Test. 2006;10:35–9. Sahore V, Kumar S, Rogers CI, et al. Pressure-actuated microfluidic devices for electrophoretic separation of pre-term birth biomarkers. Anal Bioanal Chem. 2016;408:599–607. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93:3478–83. van den Berg CB, Duvekot JJ, Güzel C, et al. Elevated levels of protein AMBP in cerebrospinal fluid of women with preeclampsia compared to normotensive pregnant women. Proteomics Clin Appl. 2017;11(1–2) doi:10.1002/prca.201600082. van Dijk M, Oudejans CB. STOX1: key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation. J Pregnancy. 2011;2011:521826. Visca E, Lapaire O, Hösli I, Hahn S. Cell-free fetal nucleic acids as prenatal biomarkers. Expert Opin Med Diagn. 2011;5:151–60. Wang T, Zhou R, Gao L, et al. Elevation of urinary adipsin in preeclampsia: correlation with urine protein concentration and the potential use for a rapid diagnostic test. Hypertension. 2014;64:846–51. Weel IC, Baergen RN, Romão-Veiga M, et al. Association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia. PLoS One. 2016;11(6):e0157584. Author information Authors and Affiliations Rights and permissions Copyright information © 2017 Springer Science+Business Media LLC About this chapter Cite this chapter Jain, K.K. (2017). Biomarkers in Gynecology and Obstetrics. In: The Handbook of Biomarkers. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7431-3_17 Download citation DOI: https://doi.org/10.1007/978-1-4939-7431-3_17 Published: Publisher Name: Humana Press, New York, NY Print ISBN: 978-1-4939-7430-6 Online ISBN: 978-1-4939-7431-3 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (22)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK